PALO ALTO, Calif.--(BUSINESS WIRE)--Bayhill Therapeutics Inc., a clinical-stage biotechnology company developing innovative therapies for autoimmune diseases, today announced that Fred Kurland joined the Company in the newly created position of Chief Financial Officer.
